Tourmaline Bio Inc (TRML)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 27,311 | 36,297 | 9,889 | 17,589 | N/A |
| Marketable Securities | 227,423 | 229,923 | 130,212 | 131,899 | N/A |
| TOTAL | $258,227 | $270,470 | $142,803 | $150,751 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 2,994 | 2,255 | 2,083 | 2,013 | N/A |
| Other Non-Current Assets | 104 | 89 | 14 | 14 | 0 |
| TOTAL | $3,098 | $2,344 | $2,097 | $2,027 | $N/A |
| Total Assets | $261,325 | $272,814 | $144,900 | $152,778 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,182 | 1,265 | 769 | 767 | 0 |
| Accrued Expenses | 3,800 | 3,396 | 2,812 | 2,637 | N/A |
| TOTAL | $4,982 | $4,661 | $3,581 | $3,404 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 694 | 800 | 187,785 | 187,520 | 0 |
| TOTAL | $694 | $800 | $187,785 | $187,520 | $N/A |
| Total Liabilities | $5,676 | $5,461 | $191,366 | $190,924 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,135 | 4,135 | 4,131 | N/A | N/A |
| Common Shares | 4 | 4 | 1 | 1 | N/A |
| Retained earnings | -76,606 | -63,665 | -52,313 | -43,014 | N/A |
| Other shareholders' equity | 29 | 34 | 9 | -13 | 0 |
| TOTAL | $255,649 | $267,353 | $-46,466 | $-38,147 | $N/A |
| Total Liabilities And Equity | $261,325 | $272,814 | $144,900 | $152,777 | $0 |